首页
订购/客服:400-666-5481

PHA-680632

    
≥98%

PHA-680632

源叶(MedMol)
S80697 一键复制产品信息
398493-79-3
C28H35N7O2
501.64
N-(2,6-diethylphenyl)-3-(4-(4-methylpiperazin-1-yl)benzamido)pyrrolo[3,4-c]pyrazole-5(1H,4H,6H)-carboxamide
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S80697-1mg促销
≥98%

¥176.00 ¥140.00

10 - - - -
S80697-5mg促销
≥98%

¥454.00 ¥360.00

10 - - - -
S80697-25mg促销
≥98%

¥2220.00 ¥1770.00

1 - - - -
S80697-100mg促销
≥98%

¥5560.00 ¥4440.00

2 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: PHA-680632 is an aurora kinase inhibitor with IC50s of 27, 135 and 120 nM for aurora A, B and C, respectively.
靶点: Aurora A:27 nM (IC50);Aurora B:135 nM (IC50);Aurora C:120 nM (IC50);FGFR;PLK;AuroraKinase
体内研究: PHA-680632 suppresses tumor growth in animal models. PHA-680632 treatment at 45 mg/kg dose results in 85% of TGI without signs of toxicity in the HL60 human acute myelogenous leukemia xenograft model. PHA-680632 treatment at 60 mg/kg i.v. b.i.d. for 5 days results in 78% of TGI without signs of toxicity in the A2780 human ovarian carcinoma model. PHA680632 in association with radiation leads to an additive effect in cancer cells, especially in the p53-deficient cells, but does not act as a radiosensitiser
参考文献: 1. Soncini C, et al. PHA-680632, a novel Aurora kinase inhibitor with potent antitumoral activity. Clin Cancer Res. 2006 Jul 1;12(13):4080-9. 2. Tao Y, et al. Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells. Br J Cancer. 2007 Dec 17;97(12):1664-72.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.993 ml 9.967 ml 19.935 ml
5 mM 0.399 ml 1.993 ml 3.987 ml
10 mM 0.199 ml 0.997 ml 1.993 ml
50 mM 0.04 ml 0.199 ml 0.399 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×